HUANZE

Overseas development information

──Feb 17 , 2021Zhuhai Port Hong Kong, a subsidiary of Zhuhai Port, has successfully acquired a 100% stake in Xinghua Port

Zhuhai Port recently announced that the company's wholly-owned subsidiary Zhuhai Port Hong Kong has successfully acquired Xinghua Port100%The shares of Xinghua Port officially became a wholly-owned subsidiary of Zhuhai Port Hong Kong, and has been in2020years11month20Delisted from the Hong Kong Stock Exchange on Tuesday. Zhuhai Port, located in the southern coast of the Pearl River Delta in Guangdong Province, is mainly engaged in the investment and operation of ports and terminals, as well as ship transportation , adjacent to Macao Special Administrative Region, is the main hub port of South China coastal, one of the main coastal ports of China, has beenDevelop into a comprehensive port combining domestic and foreign trade, passenger and freight.

Ringser's view:This acquisition is conducive to improving the comprehensive strength of Zhuhai Port. Under the premise of ensuring the normal development of the company's main business, it can reasonably allocate funds and obtain capital appreciation benefits, which is in line with the company's demand for sustainable development and stable growth. In addition, the acquisition through the Hong Kong subsidiary is because the transfer of shares of the Hong Kong company is more convenient, which saves a lot of time for the company's investment. It is also an optimal allocation of assets.

Zhuhai Port subsidiary Zhuhai Port Hong Kong successfully acquired Xinghua Port100%share

CycloseThe company focuses on providing corporate audit, tax declaration, registration, annual inspection, tax planning and other services in Hong Kong, Singapore, Dubai and other regions. Efficient, rigorous, intimate service has been favored by many private enterprises, listed companies and large state-owned enterprises.

BACK
PREV

Dawei's holding subsidiary intends to invest US $1 million to set up a Hong Kong subsidiary

NEXT

Aoxiang Pharmaceutical plans to pay $2 million for a 1% stake in Yingpai Pharmaceutical